+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
Alzheimer's Disease Drugs - Global Strategic Business Report - Product Thumbnail Image

Alzheimer's Disease Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 93 Pages
  • Global
From
Ranibizumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Ranibizumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 150 Pages
  • Global
From
From
Influenza Medication Market Report and Forecast 2023-2031 - Product Thumbnail Image

Influenza Medication Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 160 Pages
  • Global
From
From
Gastrointestinal Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Gastrointestinal Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
From
Bacteraemia - Pipeline Insight, 2025 - Product Thumbnail Image

Bacteraemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator